Last €1.99 EUR
Change Today +0.03 / 1.53%
Volume 9.6K
IKM On Other Exchanges
As of 11:39 AM 07/31/14 All times are local (Market data is delayed by at least 15 minutes).

1nkemia iuct group sa (IKM) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/28/14 - €2.80
52 Week Low
08/6/13 - €0.88
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for 1NKEMIA IUCT GROUP SA (IKM)

Related News

No related news articles were found.

1nkemia iuct group sa (IKM) Related Businessweek News

No Related Businessweek News Found

1nkemia iuct group sa (IKM) Details

1nKemia IUCT Group, S.A., a technology company, engages in the discovery, creation, development, exploitation, transfer, and license of new knowledge to chemical, pharmaceutical, biopharmaceutical, biotechnology, and life science and allied industries. It undertakes research, development, and innovation projects; designs, finances, and manages projects of high risk and high profits; and offers Knowledge Capital Fund, a seed capital fund that helps entrepreneurs in launching their innovative projects. The company also provides technological services, including analytical services, consultancy services, and technical audit, as well as services in the areas of pharmaceutical, nutraceutical, and cosmetic production; and knowledge transfer, and scientific and technical training services. In addition, it focuses on the research of synthesis procedures for nuclesidic analogues; and engages in the production of active ingredients and recombinant proteins for use in cosmetics and pharmaceutical sectors. The company is based in Barcelona, Spain.

1nkemia iuct group sa (IKM) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

1nkemia iuct group sa (IKM) Key Developments

1nKemia IUCT Group, S.A. Presents at 10th Foro MedCap, May-27-2014

1nKemia IUCT Group, S.A. Presents at 10th Foro MedCap, May-27-2014 . Venue: Palacio de la Bolsa, Plaza de la Lealtad, 1, 28014 Madrid, Spain.

Inkemia Opens Brazilian Subsidiary 'Inkemia IUCT Group Tecnologia'

Inkemia has announced the launch of its Brazilian subsidiary. The subsidiary, which is named Inkemia IUCT Group Tecnologia, will begin activities immediately from its Sao Paulo base. Inkemia first announced its intention to open a Brazilian subsidiary in December 2013. The Brazilian government is likely to be amenable to the opening of a local subsidiary by the biotech, as encouraging R&D investment in the country to facilitate technological advancements to stay internationally competitive remains high on the political agenda.

Inkemia Plans to Open Subsidiary in Brazil in 2014

Inkemia has revealed that it is planning to open a subsidiary in Brazil in 2014, as part of an international expansion strategy. The Brazilian subsidiary will be operational during the first quarter of the year, and will focus on the transfer of knowledge via scientific training and organising conferences. Inkemia aims to grow its operations in Brazil by means of local personnel and by forging agreements with local partners.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IKM:SM €1.99 EUR +0.03

IKM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for IKM.
View Industry Companies

Industry Analysis


Industry Average

Valuation IKM Industry Range
Price/Earnings 55.4x
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow 24.2x
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact 1NKEMIA IUCT GROUP SA, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at